ロード中...
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
OBJECTIVE: Exenatide belongs to a new therapeutic class in the treatment of diabetes (incretin mimetics), allowing glucose-dependent glycaemic control in Type 2 diabetes. Randomised controlled trial data suggest that exenatide is as effective as insulin glargine at reducing HbA(1c )in combination th...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2546382/ https://ncbi.nlm.nih.gov/pubmed/18694484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-7-24 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|